Torrent Pharmaceuticals Limited
Torrent Pharma shareholders have approved the Scheme of Amalgamation with J.B. Chemicals & Pharmaceuticals Limited at a meeting held on April 28, 2026. This approval is a key step towards completing the merger.
Apr 28 2026 22:04:00
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals shareholders approved the scheme of amalgamation with J. B. Chemicals & Pharmaceuticals Limited. The approval was passed by a requisite majority at the NCLT convened meeting held on April 28, 2026.
Apr 28 2026 22:04:00
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals' equity shareholders approved the scheme of amalgamation with J. B. Chemicals & Pharmaceuticals Limited. This approval was obtained in an NCLT-convened meeting with the requisite majority, allowing the merger to proceed as planned.
Apr 28 2026 21:04:00
Torrent Pharmaceuticals Ltd - 500420 - Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
Torrent Pharma's equity shareholders have approved the proposed Scheme of Amalgamation with J. B. Chemicals & Pharmaceuticals Limited (JB Pharma). The approval was granted with the requisite majority at the NCLT-convened meeting held on April 28, 2026, marking a significant step in the merger process.
Apr 28 2026 21:04:00
Torrent Pharmaceuticals Limited
Torrent Pharma filed a disclosure regarding post-listing non-convertible debentures (NCDs) in compliance with SEBI regulations. The filing provides comprehensive details of NCDs issued and outstanding as of March 31, 2026, and confirms no default history in debt servicing.
Apr 23 2026 19:04:00
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals disclosed details of listed debt securities issued through private placement for the half year ended March 31, 2026. The disclosure includes approximately ₹10,990 crore in outstanding NCDs across four issuances with coupon rates up to 7.80%, and confirmed the redemption of NCDs (ISIN INE685A07082) on December 12, 2025.
Apr 15 2026 11:04:00
Torrent Pharmaceuticals Limited
Torrent Pharma's Bileshwarpura (Oncology) facility underwent a USFDA inspection from April 6-10, 2026. The inspection concluded with zero observations, indicating compliance with regulatory standards.
Apr 10 2026 19:04:00
Torrent Pharmaceuticals Ltd - 500420 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Torrent Pharma's Bileshwarpura (Oncology) facility underwent a USFDA inspection from 06-Apr-26 to 10-Apr-26. The inspection concluded successfully with zero observations, indicating high compliance standards.
Apr 10 2026 19:04:00
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals confirmed the full utilization of Commercial Papers proceeds by March 31, 2026. This utilization was in line with the purpose disclosed in the Disclosure Document and adhered to SEBI regulations.
Apr 06 2026 17:04:00
Read More